Azmarda (Sacubitril Valsartan)

Azmarda Sacubitril/ Valsartan is indicated in adults with long-term heart failure who have symptoms of the disease to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure (NYHA Class II-IV) and reduced ejection fraction. Read more at https://medicaldialogues.in/partner/jbcpl/azmarda-sacubitril-valsartan